Literature DB >> 3228594

Primary synchronous bilateral breast cancer: epidemiological approach.

J Kelmendi de Ustarán1, R P Meiss.   

Abstract

Twenty-eight (1.69%) cases of primary synchronous bilateral breast cancer (PSBC) out of 1,654 new cases were studied. PSBC compared with unilateral cases had a significantly higher (p less than 0.001) first degree family history of breast cancer; high frequency of subareolar location; no predominance of lobular and non-invasive types; no significantly different percentage of pathological stage I presentation. As there is no complete agreement on what constitutes a PSBC, studies should be carried out to formulate a more precise definition of this entity.

Entities:  

Mesh:

Year:  1988        PMID: 3228594     DOI: 10.1007/bf01811245

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Bilateral breast cancer: biopsy of the opposite breast.

Authors:  J A Urban; D Papachristou; J Taylor
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

Review 2.  Epidemiology of breast cancer; a review.

Authors:  F de Waard
Journal:  Eur J Cancer Clin Oncol       Date:  1983-12

3.  Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma.

Authors:  M Nielsen; L Christensen; J Andersen
Journal:  Cancer       Date:  1986-03-01       Impact factor: 6.860

4.  A contribution to the natural history of breast cancer. V. Bilateral primary breast cancer: incidence, risks and diagnosis of simultaneous primary cancer in the opposite breast.

Authors:  A H Tulusan; G Ronay; H Egger; F Willgeroth
Journal:  Arch Gynecol       Date:  1985

5.  Progress against cancer?

Authors:  J C Bailar; E M Smith
Journal:  N Engl J Med       Date:  1986-05-08       Impact factor: 91.245

6.  Bilateral primary breast cancer: a prospective study of disease incidence.

Authors:  M A Chaudary; R R Millis; E O Hoskins; M Halder; R D Bulbrook; J Cuzick; J L Hayward
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

7.  Bilateral breast cancer at the Johns Hopkins Hospital. A discussion of the dilemma of contralateral breast cancer.

Authors:  E F Lewison; A S Neto
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

8.  Biological and histological characteristics of simultaneous bilateral breast cancer.

Authors:  D T Kiang; B J Kennedy; D C Snover
Journal:  Lancet       Date:  1980-11-22       Impact factor: 79.321

9.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.

Authors:  E R Fisher; B Fisher; R Sass; L Wickerham
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

10.  Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study.

Authors:  H O Adami; R Bergström; J Hansen
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

View more
  4 in total

1.  Synchronous Bilateral Breast Cancers.

Authors:  Naveen Padmanabhan; Annapurneswari Subramanyan; Selvi Radhakrishna
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Techniques for Treating Bilateral Breast Cancer Patients Using Pencil Beam Scanning Technology.

Authors:  Melissa A L Vyfhuis; Mingyao Zhu; Benjamin Agyepong; Elizabeth M Nichols
Journal:  Int J Part Ther       Date:  2019-09-24

3.  HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast.

Authors:  Katsumi Kito; Toshiharu Maeda; Keiko Ninomiya; Atsuro Sugita; Teiri Sagawa; Kinya Matsuoka; Kousei Kinoshita; Naoki Hyodo; Nagisa Morita; Keizo Furuya
Journal:  Case Rep Pathol       Date:  2014-09-18

4.  Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).

Authors:  Hanfang Jiang; Ruyan Zhang; Xiaoran Liu; Ran Ran; Jiayang Zhang; Yaxin Liu; Xinyu Gui; Yifei Chen; Kun Li; Bin Shao; Ying Yan; Xu Liang; Guohong Song; Lijun Di; Huiping Li
Journal:  Cancer Med       Date:  2021-08-04       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.